Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Anticarcinogenic Agents | 2 | 2018 | 25 | 1.40 | Why? |
| Neoplasms, Multiple Primary | 2 | 2017 | 61 | 1.28 | Why? |
| Carcinoma | 2 | 2017 | 256 | 1.03 | Why? |
| Colorectal Neoplasms | 5 | 2018 | 1884 | 0.88 | Why? |
| Aberrant Crypt Foci | 1 | 2017 | 1 | 0.74 | Why? |
| Adenoma | 2 | 2017 | 215 | 0.67 | Why? |
| Glucuronidase | 1 | 2017 | 103 | 0.62 | Why? |
| Memory | 1 | 2017 | 137 | 0.61 | Why? |
| Executive Function | 1 | 2017 | 173 | 0.57 | Why? |
| Data Collection | 2 | 2020 | 1769 | 0.52 | Why? |
| Colonic Neoplasms | 1 | 2017 | 295 | 0.52 | Why? |
| Mobile Applications | 6 | 2021 | 3032 | 0.51 | Why? |
| Body Composition | 1 | 2017 | 414 | 0.50 | Why? |
| Chemoprevention | 1 | 2018 | 585 | 0.50 | Why? |
| Diabetic Nephropathies | 1 | 2017 | 315 | 0.50 | Why? |
| Escherichia coli | 1 | 2018 | 1547 | 0.40 | Why? |
| Cognitive Dysfunction | 2 | 2017 | 1389 | 0.36 | Why? |
| Aspirin | 1 | 2017 | 1043 | 0.36 | Why? |
| Gastrointestinal Microbiome | 3 | 2018 | 1961 | 0.36 | Why? |
| International Cooperation | 1 | 2020 | 3436 | 0.31 | Why? |
| Smoking | 1 | 2017 | 3358 | 0.25 | Why? |
| Self Report | 5 | 2021 | 3802 | 0.25 | Why? |
| Kidney | 1 | 2017 | 3648 | 0.24 | Why? |
| Kidney Failure, Chronic | 1 | 2017 | 3222 | 0.21 | Why? |
| Microsatellite Instability | 2 | 2017 | 57 | 0.21 | Why? |
| Renal Dialysis | 1 | 2017 | 4358 | 0.20 | Why? |
| Prodromal Symptoms | 1 | 2020 | 133 | 0.20 | Why? |
| CpG Islands | 2 | 2017 | 230 | 0.19 | Why? |
| Proto-Oncogene Proteins B-raf | 2 | 2017 | 179 | 0.18 | Why? |
| Glucosinolates | 1 | 2018 | 13 | 0.18 | Why? |
| Isothiocyanates | 1 | 2018 | 29 | 0.18 | Why? |
| Mental Status Schedule | 1 | 2017 | 34 | 0.17 | Why? |
| Prostaglandins | 1 | 2017 | 21 | 0.17 | Why? |
| Prospective Studies | 13 | 2021 | 43301 | 0.17 | Why? |
| Microbiota | 2 | 2018 | 1240 | 0.17 | Why? |
| Diet, Western | 1 | 2017 | 42 | 0.17 | Why? |
| Patient Dropouts | 1 | 2017 | 96 | 0.16 | Why? |
| Biological Availability | 1 | 2018 | 388 | 0.16 | Why? |
| Diagnosis, Computer-Assisted | 1 | 2021 | 436 | 0.15 | Why? |
| Metagenome | 1 | 2018 | 268 | 0.15 | Why? |
| DNA Methylation | 2 | 2017 | 688 | 0.14 | Why? |
| United Kingdom | 8 | 2021 | 18046 | 0.14 | Why? |
| Disease Notification | 1 | 2020 | 639 | 0.13 | Why? |
| Feces | 2 | 2018 | 4235 | 0.13 | Why? |
| Protective Factors | 2 | 2017 | 1720 | 0.13 | Why? |
| Nursing Research | 1 | 2017 | 181 | 0.13 | Why? |
| United States | 10 | 2021 | 46150 | 0.13 | Why? |
| Boston | 1 | 2017 | 929 | 0.13 | Why? |
| Dyspnea | 3 | 2021 | 3847 | 0.13 | Why? |
| Ageusia | 1 | 2021 | 918 | 0.13 | Why? |
| Smartphone | 2 | 2020 | 1840 | 0.11 | Why? |
| Biomarkers, Tumor | 2 | 2017 | 1314 | 0.11 | Why? |
| Drug-Related Side Effects and Adverse Reactions | 1 | 2021 | 1261 | 0.11 | Why? |
| Colonoscopy | 1 | 2017 | 738 | 0.10 | Why? |
| Cough | 2 | 2021 | 4891 | 0.10 | Why? |
| Linear Models | 1 | 2017 | 1914 | 0.10 | Why? |
| Middle Aged | 19 | 2021 | 270681 | 0.10 | Why? |
| Risk Reduction Behavior | 1 | 2017 | 946 | 0.10 | Why? |
| Gene Expression Profiling | 2 | 2018 | 3788 | 0.10 | Why? |
| Models, Biological | 3 | 2021 | 4907 | 0.10 | Why? |
| Aged | 15 | 2021 | 215776 | 0.09 | Why? |
| Multivariate Analysis | 2 | 2017 | 5440 | 0.09 | Why? |
| Male | 20 | 2021 | 367725 | 0.09 | Why? |
| Time Factors | 5 | 2021 | 31397 | 0.09 | Why? |
| Smoking Cessation | 1 | 2017 | 826 | 0.09 | Why? |
| Software | 1 | 2020 | 2501 | 0.09 | Why? |
| Cognition | 1 | 2017 | 1394 | 0.09 | Why? |
| Disease Progression | 2 | 2017 | 13580 | 0.09 | Why? |
| Female | 19 | 2021 | 380317 | 0.09 | Why? |
| Proportional Hazards Models | 2 | 2017 | 6543 | 0.08 | Why? |
| Gene Expression | 1 | 2018 | 3332 | 0.08 | Why? |
| Public Health Surveillance | 1 | 2020 | 3129 | 0.08 | Why? |
| Mice, Inbred BALB C | 1 | 2018 | 5814 | 0.08 | Why? |
| Artificial Intelligence | 1 | 2021 | 3543 | 0.08 | Why? |
| Phenotype | 1 | 2017 | 4037 | 0.07 | Why? |
| Double-Blind Method | 1 | 2017 | 5988 | 0.07 | Why? |
| Risk Factors | 7 | 2021 | 71621 | 0.07 | Why? |
| Clinical Protocols | 1 | 2017 | 2734 | 0.07 | Why? |
| Inflammation Mediators | 1 | 2017 | 2654 | 0.07 | Why? |
| Adult | 15 | 2021 | 244371 | 0.07 | Why? |
| Cohort Studies | 3 | 2018 | 36005 | 0.07 | Why? |
| Longitudinal Studies | 2 | 2018 | 9893 | 0.07 | Why? |
| Antineoplastic Agents | 1 | 2020 | 3550 | 0.07 | Why? |
| Feeding Behavior | 1 | 2017 | 1909 | 0.07 | Why? |
| Population Surveillance | 1 | 2021 | 4967 | 0.07 | Why? |
| Follow-Up Studies | 3 | 2018 | 17020 | 0.07 | Why? |
| Fever | 1 | 2021 | 7795 | 0.07 | Why? |
| Humans | 24 | 2021 | 930598 | 0.07 | Why? |
| Sex Factors | 2 | 2020 | 11014 | 0.06 | Why? |
| Age Factors | 3 | 2021 | 21039 | 0.06 | Why? |
| Renal Insufficiency, Chronic | 1 | 2017 | 2654 | 0.06 | Why? |
| Metagenomics | 2 | 2018 | 823 | 0.06 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.06 | Why? |
| Young Adult | 7 | 2021 | 93724 | 0.06 | Why? |
| African Americans | 1 | 2017 | 3363 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Models, Theoretical | 1 | 2020 | 6659 | 0.05 | Why? |
| Transplant Recipients | 1 | 2017 | 4982 | 0.05 | Why? |
| Aging | 1 | 2017 | 3581 | 0.05 | Why? |
| Research Design | 1 | 2017 | 5830 | 0.05 | Why? |
| Mortality | 1 | 2017 | 7132 | 0.05 | Why? |
| Mutation | 2 | 2017 | 12376 | 0.05 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.05 | Why? |
| Computer Systems | 1 | 2020 | 255 | 0.05 | Why? |
| Epidemiologic Studies | 1 | 2021 | 554 | 0.05 | Why? |
| Masks | 1 | 2021 | 8528 | 0.05 | Why? |
| Adolescent | 5 | 2021 | 86841 | 0.05 | Why? |
| Surveys and Questionnaires | 3 | 2020 | 43792 | 0.04 | Why? |
| Odds Ratio | 2 | 2021 | 5861 | 0.04 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.04 | Why? |
| Kidney Transplantation | 1 | 2017 | 5397 | 0.04 | Why? |
| Proto-Oncogene Proteins p21(ras) | 1 | 2017 | 100 | 0.04 | Why? |
| Chest Pain | 1 | 2021 | 578 | 0.04 | Why? |
| Global Health | 1 | 2020 | 13911 | 0.04 | Why? |
| Aged, 80 and over | 4 | 2021 | 88759 | 0.04 | Why? |
| Personal Protective Equipment | 1 | 2020 | 15978 | 0.04 | Why? |
| Vaccination | 1 | 2021 | 19050 | 0.04 | Why? |
| Case Management | 1 | 2017 | 285 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Prevalence | 1 | 2017 | 25773 | 0.03 | Why? |
| Cytokines | 1 | 2017 | 15010 | 0.03 | Why? |
| Predictive Value of Tests | 2 | 2021 | 9537 | 0.03 | Why? |
| Safety | 1 | 2021 | 1583 | 0.03 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.03 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.03 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.03 | Why? |
| Gene Regulatory Networks | 1 | 2018 | 820 | 0.03 | Why? |
| Israel | 1 | 2021 | 2751 | 0.03 | Why? |
| Early Diagnosis | 1 | 2021 | 2443 | 0.03 | Why? |
| Neuropsychological Tests | 1 | 2017 | 954 | 0.03 | Why? |
| Neoplasms | 1 | 2020 | 17251 | 0.03 | Why? |
| Cardiovascular Diseases | 1 | 2017 | 11497 | 0.03 | Why? |
| Nurses | 2 | 2017 | 2285 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2017 | 1638 | 0.03 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.03 | Why? |
| Fatigue | 1 | 2020 | 2479 | 0.02 | Why? |
| England | 1 | 2020 | 5116 | 0.02 | Why? |
| Taste Disorders | 1 | 2020 | 1720 | 0.02 | Why? |
| Sensitivity and Specificity | 2 | 2021 | 22971 | 0.02 | Why? |
| Animals | 1 | 2018 | 78931 | 0.02 | Why? |
| Bacteria | 1 | 2018 | 1897 | 0.02 | Why? |
| Health Status | 1 | 2020 | 3259 | 0.02 | Why? |
| High-Throughput Nucleotide Sequencing | 1 | 2018 | 3633 | 0.02 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.02 | Why? |
| Public Health | 2 | 2021 | 16359 | 0.02 | Why? |
| Olfaction Disorders | 1 | 2020 | 3704 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Phylogeny | 1 | 2018 | 13341 | 0.01 | Why? |
| Retrospective Studies | 2 | 2021 | 105322 | 0.01 | Why? |
| Physicians | 1 | 2017 | 4214 | 0.01 | Why? |
| Disease Transmission, Infectious | 1 | 2021 | 9044 | 0.01 | Why? |
| Quality of Life | 1 | 2017 | 9820 | 0.01 | Why? |
| Clinical Laboratory Techniques | 1 | 2020 | 23402 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |